Who Should and Who Should Not Be Vaccinated Against Human Papillomavirus Infection?
- Published in:
- European Journal of Oncological Medicine, 2010, v. 2, n. 2, p. 3, doi. 10.5083/ejom.20424981.21
- By:
- Publication type:
- Article
Works matching IS 20424981 AND DT 2010 AND VI 2 AND IP 2
Results: 7
1
2
Use Of Granisetron Transdermal System In The Prevention Of Chemotherapy-Induced Nausea And Vomiting: A Review.
- Published in:
- European Journal of Oncological Medicine, 2010, v. 2, n. 2, p. 58, doi. 10.5083/ejom.20424981.10
- By:
- Publication type:
- Article
3
Preoperative Carcino-embryonic Antigen and Carbohydrate Antigen 19-9 Serum Levels: Which Usefulness in Localised Colorectal Cancer?
- Published in:
- 2010
- By:
- Publication type:
- Art Reproduction
4
Management Of Side Effects Associated With Sunitinib Therapy For Patients With Renal Cell Carcinoma.
- Published in:
- European Journal of Oncological Medicine, 2010, v. 2, n. 2, p. 68, doi. 10.5083/ejom.20424981.11
- By:
- Publication type:
- Article
5
Current Concepts: Pulmonary Metastasectomy for Colorectal Cancer.
- Published in:
- European Journal of Oncological Medicine, 2010, v. 2, n. 2, p. 2, doi. 10.5083/ejom.20424981.10
- By:
- Publication type:
- Article
6
CD133+ circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients.
- Published in:
- European Journal of Oncological Medicine, 2010, v. 2, n. 2, p. 48, doi. 10.5083/ejom.20424981.09
- By:
- Publication type:
- Article
7
Biological and Physical Determinants of Tumour Resistance.
- Published in:
- European Journal of Oncological Medicine, 2010, v. 2, n. 2, p. 6, doi. 10.5083/ejom.20424981.20
- By:
- Publication type:
- Article